Demonstration of multiple regulatory factors for purified human leukocyte 5-lipoxygenaseROUZER, C. A; SAMUELSSON, B.Advances in enzyme regulation. 1987, Vol 26, pp 133-144, issn 0065-2571Conference Paper

The monocyte-derived neutrophil activating peptide (NAP/interleukin 8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonateSCHRODER, J. -M.The Journal of experimental medicine. 1989, Vol 170, Num 3, pp 847-863, issn 0022-1007Article

The expression of 5-lipoxygenase in lymphoblastoid B and T cellsEL MAKHOUR-HOJEIJ, Y; BACLET, M. C; CHABLE-RABINOVITCH, H et al.Prostaglandins. 1994, Vol 48, Num 1, pp 21-29, issn 0090-6980Article

Immunohistochemical study on arachidonate 5-lipoxygenase in porcine leukocytes and other tissuesKOMATSU, N; NATSUI, K; UEDA, N et al.The Journal of histochemistry and cytochemistry. 1991, Vol 39, Num 5, pp 655-662, issn 0022-1554Article

Reversible, calcium-dependent membrane association of human leukocyte 5-lipoxygenaseROUZER, C. A; SAMUELSSON, B.Proceedings of the National Academy of Sciences of the United States of America. 1987, Vol 84, Num 21, pp 7393-7397, issn 0027-8424Article

Characterization of monoclonal antibodies against human leukocyte 5-lipoxygenaseETHIER, D; EVANS, J. F.Prostaglandins, leukotrienes and essential fatty acids. 1992, Vol 45, Num 4, pp 259-265, issn 0952-3278Article

Differences in arachidonic acid release, metabolism and leukotriene B₄ synthesis in human polymorphonuclear leukocytes activated by differential stimuliSELLMAYER, A; STRASSER, T; WEBER, P. C et al.Biochimica et biophysica acta. 1987, Vol 927, Num 3, pp 417-422, issn 0006-3002Article

Polymorphonuclear leukocyte 5-lipoxygenase activity in psoriasisRUZICKA, T; RADSPIELER, H; STRASSER, T et al.Prostaglandins leukotrienes and medicine. 1985, Vol 18, Num 3, pp 313-319, issn 0262-1746Article

Characterization of the non-heme iron center of human 5-lipoxygenase by electron paramagnetic resonance, fluorescence, and ultraviolet-visible spectroscopy : redox cycling between ferrous and ferric statesCHASTEEN, N. D; GRADY, J. K; SKOREY, K. I et al.Biochemistry (Easton). 1993, Vol 32, Num 37, pp 9763-9771, issn 0006-2960Article

A rat air pouch model for evaluating the efficacy and selectivity of 5-lipoxygenase inhibitorsZWEIFEL, Ben S; HARDY, Medora M; ANDERSON, Gary D et al.European journal of pharmacology. 2008, Vol 584, Num 1, pp 166-174, issn 0014-2999, 9 p.Article

Lipoxygenase inhibitors from natural plant sources. Part 1: Medicinal plants with inhibitory activity on arachidonate 5-lipoxygenase and 5-lipoxygenase/cyclooxygenaseSCHNEIDER, Isabella; BUCAR, Franz.PTR. Phytotherapy research. 2005, Vol 19, Num 2, pp 81-102, issn 0951-418X, 22 p.Article

A 5-lipoxygenase inhibitor at micromolar concentration raises intracellular calcium in U937 cells prior to their physiologic cell deathBUYN, T; DUDEJA, P; HARRIS, J. E et al.Prostaglandins, leukotrienes and essential fatty acids. 1997, Vol 56, Num 1, pp 69-77, issn 0952-3278Article

Les anti-leucotriènes : Leur positionnement dans l'asthme = Leukotrienes antagonists : Their interest in asthmaDEVILLIER, P; MILLART, H; ADVENIER, C et al.Revue médicale de Bruxelles. 1997, Vol 18, Num 4, pp 279-285, issn 0035-3639Conference Paper

Modulators of leukotriene biosynthesis and receptor activationBROOKS, C. D. W; SUMMERS, J. B.Journal of medicinal chemistry (Print). 1996, Vol 39, Num 14, pp 2629-2654, issn 0022-2623Article

Noradrenaline and dopamine infusions modulate arachidonic acid cyclooxygenase and 5-lipoxygenase pathways ex vivo in manKERTTULA, T; RIUTTA, A; KAUKINEN, S et al.Prostaglandins, leukotrienes and essential fatty acids. 1995, Vol 53, Num 1, pp 47-52, issn 0952-3278Article

USF-19A, a new lipoxygenase inhibitor from Streptomyces spKOMODA, T; MORIMITSU, Y; HIROTA, H et al.Bioscience, biotechnology, and biochemistry. 1995, Vol 59, Num 5, pp 924-926, issn 0916-8451Article

Leukotriene formation by mouse connective tissue mast cellsJAKSCHIK, B. A; HARRINGTON, L. F; MALAVIYA, R et al.Eicosanoids. 1992, Vol 5, Num 1, pp 39-43, issn 0934-9820Article

Molecular evolution of cyclooxygenase and lipoxygenaseTOH, H; YOKOYAMA, C; TANABE, T et al.Prostaglandins. 1992, Vol 44, Num 4, pp 291-315, issn 0090-6980Article

Pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in the management of asthmaDRAZEN, J. M.Pharmacotherapy. 1997, Vol 17, Num 1, pp 22S-30S, issn 0277-0008, 2Conference Paper

Zileuton : A new therapy for asthma or just the first of a new class of drugs ?HENDELES, L; MARSHIK, P. L.The Annals of pharmacotherapy. 1996, Vol 30, Num 7-8, pp 873-875, issn 1060-0280Article

Stereoselective glucuronidation of zileuton isomers by human hepatic microsomesSWEENY, D. J; NELLANS, H. N.Drug metabolism and disposition. 1995, Vol 23, Num 1, pp 149-153, issn 0090-9556Article

Induction of apoptosis in blood cells from a patient with acute myelogenous leukemia by SC41661A, a selective inhibitor of 5-lipoxygenaseANDERSON, K. M; LEVIN, J; JAJEH, A et al.Prostaglandins, leukotrienes and essential fatty acids. 1993, Vol 48, Num 4, pp 323-326, issn 0952-3278Article

Use of a continuous assay of oxygen consumption to evaluate the pharmacology of 5-lipoxygenase inhibitorsBRETON, J; KELLER, P; CHABOT-FLETCHER, M et al.Prostaglandins, leukotrienes and essential fatty acids. 1993, Vol 49, Num 6, pp 929-937, issn 0952-3278Article

Modulatory effect of arachidonate 5-lipoxygenation on glomerular cell proliferation in neprhotoxic serum nephritisSHENG-HUE WU; LIANOS, E. A.The Journal of laboratory and clinical medicine. 1993, Vol 122, Num 6, pp 703-710, issn 0022-2143Article

Mutagenesis of some conserved residues in human 5-lipoxygenase : effects on enzyme activityYING YI ZHANG; RADMARK, O; SAMUELSSON, B et al.Proceedings of the National Academy of Sciences of the United States of America. 1992, Vol 89, Num 2, pp 485-489, issn 0027-8424Article